Rational use of medications: If Canada can't do it ...

被引:4
作者
Califf, Robert M. [1 ]
机构
[1] Duke Univ, Med Ctr, Duke Translat Med Inst, Durham, NC 27710 USA
关键词
QUALITY;
D O I
10.1503/cmaj.090861
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:15 / 16
页数:2
相关论文
共 7 条
[1]
Integrating quality into the cycle of therapeutic development [J].
Califf, RM ;
Peterson, ED ;
Gibbons, RJ ;
Garson, A ;
Brindis, RG ;
Beller, GA ;
Smith, SC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (11) :1895-1901
[2]
The Cost of Biopharmaceutical R&D: Is Biotech Different? [J].
DiMasi, Joseph A. ;
Grabowski, Henry G. .
MANAGERIAL AND DECISION ECONOMICS, 2007, 28 (4-5) :469-479
[3]
The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence mortality and cost [J].
Goldman, L ;
Phillips, KA ;
Coxson, P ;
Goldman, PA ;
Williams, L ;
Hunink, M ;
Weinstein, MC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (04) :1012-1017
[4]
JACKEVICIUS CA, 2009, CMAJ, V181, P45
[5]
USE OF MEDICAL RESOURCES AND QUALITY-OF-LIFE AFTER ACUTE MYOCARDIAL-INFARCTION IN CANADA AND THE UNITED-STATES [J].
MARK, DB ;
NAYLOR, CD ;
HLATKY, MA ;
CALIFF, RM ;
TOPOL, EJ ;
GRANGER, CB ;
KNIGHT, JD ;
NELSON, CL ;
LEE, KL ;
CLAPPCHANNING, NE ;
SUTHERLAND, W ;
PILOTE, L ;
ARMSTRONG, PW .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (17) :1130-1135
[6]
From the analyst's couch - Clinical forecasting in drug development [J].
Schachter, Asher D. ;
Ramoni, Marco F. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (02) :107-108
[7]
Unwarranted variations in healthcare delivery: implications for academic medical centres [J].
Wennberg, JE .
BRITISH MEDICAL JOURNAL, 2002, 325 (7370) :961-964